Black Rock Inc. Jasper Therapeutics, Inc. Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.42 - $0.93 $1,338 - $2,964	3,188 Added 0.24%	1,323,972 $1.05 Million
Q3 2023 Nov 13, 2023	SELL	$0.68 - $1.54 $7,862 - $17,807	-11,563 Reduced 0.87%	1,320,784 $924,000
Q2 2023 Aug 11, 2023	BUY	$1.19 - $1.79 $90,237 - $135,735	75,830 Added 6.03%	1,332,347 $1.83 Million
Q1 2023 May 12, 2023	BUY	$1.48 - $2.74 $1.54 Million - $2.86 Million	1,042,394 Added 486.82%	1,256,517 $2.27 Million
Q4 2022 Feb 13, 2023	BUY	$0.46 - $8.9 $504 - $9,754	1,096 Added 0.51%	214,123 $102,000
Q3 2022 Nov 14, 2022	SELL	$0.08 - $22.6 $403 - $114,062	-5,047 Reduced 2.31%	213,027 $168,000
Q2 2022 Aug 12, 2022	BUY	$1.73 - $3.86 $83,913 - $187,229	48,505 Added 28.6%	218,074 $421,000
Q1 2022 May 12, 2022	BUY	$2.96 - $8.01 $224 - $608	76 Added 0.04%	169,569 $603,000
Q4 2021 Feb 10, 2022	BUY	$7.21 - $16.42 $1.22 Million - $2.78 Million	169,493 New	169,493 $1.33 Million

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $821M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.